Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kitty Pavlakis

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Cancers|January 11, 2022
Prognostic Significance of <i>SLFN11</i> Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian CancerVictoria Tserpeli, Dimitra Stergiopoulou, Dora Londra, et al.
Pathology Oncology Research : POR|August 8, 2014
p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumabKitty Pavlakis, Mattheos Bobos, Anna Batistatou, et al.
Anticancer Research|July 1, 2015
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group TrialHelena Linardou, Konstantine T Kalogeras, Ralf Kronenwett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Dynamic spectral imaging: improving colposcopyWilliam P Soutter, Emmanuel Diakomanolis, Deirdre Lyons, et al.
Cancer Research and Treatment|November 18, 2021
Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based RegimensHelen P Kourea, Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, et al.
Anticancer Research|May 7, 2017
Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast CancerTitika-Marina Strati, Vassiliki Kotoula, Ioannis Kostopoulos, et al.
Clinical Breast Cancer|November 9, 2019
The Role of CXCL13 and CXCL9 in Early Breast CancerEvangelia Razis, Konstantine T Kalogeras, Ioannis Kotsantis, et al.
Breast Cancer Research and Treatment|March 16, 2006
Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapyIoannis Kostopoulos, Petroula Arapantoni-Dadioti, Helen Gogas, et al.
Anticancer Research|May 29, 2017
The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant ChemotherapyTheofani Gavressea, Konstantine T Kalogeras, Georgia-Angeliki Koliou, et al.
Translational Oncology|March 17, 2019
Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with TrastuzumabPanagiota Economopoulou, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Cancers|January 11, 2022
Prognostic Significance of <i>SLFN11</i> Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian CancerVictoria Tserpeli, Dimitra Stergiopoulou, Dora Londra, et al.
Pathology Oncology Research : POR|August 8, 2014
p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumabKitty Pavlakis, Mattheos Bobos, Anna Batistatou, et al.
Anticancer Research|July 1, 2015
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group TrialHelena Linardou, Konstantine T Kalogeras, Ralf Kronenwett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Dynamic spectral imaging: improving colposcopyWilliam P Soutter, Emmanuel Diakomanolis, Deirdre Lyons, et al.
Cancer Research and Treatment|November 18, 2021
Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based RegimensHelen P Kourea, Foteinos-Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, et al.
Anticancer Research|May 7, 2017
Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast CancerTitika-Marina Strati, Vassiliki Kotoula, Ioannis Kostopoulos, et al.
Clinical Breast Cancer|November 9, 2019
The Role of CXCL13 and CXCL9 in Early Breast CancerEvangelia Razis, Konstantine T Kalogeras, Ioannis Kotsantis, et al.
Breast Cancer Research and Treatment|March 16, 2006
Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapyIoannis Kostopoulos, Petroula Arapantoni-Dadioti, Helen Gogas, et al.
Anticancer Research|May 29, 2017
The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant ChemotherapyTheofani Gavressea, Konstantine T Kalogeras, Georgia-Angeliki Koliou, et al.
Translational Oncology|March 17, 2019
Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with TrastuzumabPanagiota Economopoulou, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.
Pageof 8